Amryt Pharma (AMYT) News Today GBX 143 -19.00 (-11.73%) (As of 01/10/2022) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Amryt Pharma plc (AMYT)August 21, 2024 | finance.yahoo.comAmryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi FarmaceuticiMarch 22, 2023 | finance.yahoo.comChiesi Farmaceutici S.p.A. to acquire Amryt PharmaJanuary 16, 2023 | msn.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Amryt Pharma Plc BuyoutJanuary 10, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBOJanuary 9, 2023 | benzinga.comAMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to ShareholdersJanuary 9, 2023 | technews.tmcnet.comItaly's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion dealJanuary 8, 2023 | news.yahoo.comChiesi Farmaceutici S.p.A. to Acquire Amryt Pharma PlcJanuary 8, 2023 | au.finance.yahoo.comEuropean Commission approves Mycapssa® for the treatment of AcromegalyDecember 5, 2022 | ca.finance.yahoo.comAmryt Supports Acromegaly Awareness Day 2022October 31, 2022 | nz.finance.yahoo.comAmryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)October 17, 2022 | finance.yahoo.comAMYT Amryt Pharma plcOctober 15, 2022 | seekingalpha.comAmryt Pharma plc (AMYT) CEO Joseph Wiley on Q2 2022 Results - Earnings Call TranscriptAugust 6, 2022 | seekingalpha.comAmryt Pharma PLC Sponsored ADR (AMYT) Reports Q2 Loss, Tops Revenue EstimatesAugust 4, 2022 | finance.yahoo.comAmryt Pharma PLC ADR Stock Quote AMYTJuly 30, 2022 | morningstar.comAmryt Pharma appoints Dr Tracy Cunningham as Chief Medical OfficerJune 27, 2022 | seekingalpha.comAmryt to Pursue Formal FDA Resolution for Oleogel-S10 >AMYTJune 25, 2022 | marketwatch.comFilsuvez's European Approval Adds Growth Driver For Amryt PharmaJune 24, 2022 | finance.yahoo.comAmryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDAJune 24, 2022 | nasdaq.comAmryt Announces Details of EMA Contingent Value Rights PaymentMay 17, 2022 | finance.yahoo.comAmryt Announces New Patent for Mycapssa®May 11, 2022 | uk.finance.yahoo.comAmryt Pharma PLC (AMYT) CEO Joseph Wiley on Q1 2022 Results - Earnings Call TranscriptMay 8, 2022 | seekingalpha.comAmryt stock rises 10% as EMA panel backs approval of Filsuvez to treat skin disorder in EUApril 22, 2022 | seekingalpha.comAmryt Posts Long-Term Safety, Efficacy Mycapssa Data In Acromegaly PatientsApril 13, 2022 | finance.yahoo.comAmryt Pharma PLC Rings the Opening BellMarch 17, 2022 | nasdaq.comThe Law Offices of Frank R. Cruz Announces Investigation of Amryt Pharma plc (AMYT) on Behalf of InvestorsMarch 8, 2022 | tmcnet.comA Preview Of Amryt Pharma's EarningsMarch 8, 2022 | benzinga.comAmryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules)March 8, 2022 | uk.finance.yahoo.comKirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Amryt Pharma plc (AMYT) InvestorsMarch 3, 2022 | apnews.comAmryt Down on FDA ContactFebruary 28, 2022 | baystreet.caAmryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDAFebruary 28, 2022 | finance.yahoo.comAmryt Announces New Patents for Oleogel-S10January 18, 2022 | finance.yahoo.comTimothy P. Lynch’s Stonepine Capital Portfolio: Top 10 Healthcare StocksDecember 11, 2021 | finance.yahoo.comAmryt's Skin Disorder Drug Application Review With FDA Extended By Three MonthsNovember 23, 2021 | markets.businessinsider.comAmryt Provides Update on Regulatory Review Process for Oleogel-S10November 23, 2021 | finance.yahoo.comAmryt Reports Strong Q3 2021 ResultsNovember 3, 2021 | finance.yahoo.comAmryt Pharma PLC : Amryt Supports Global FH Awareness DaySeptember 30, 2021 | markets.businessinsider.comAmryt Raises Full Year 2021 Revenue Guidance to $220M - $225MSeptember 13, 2021 | finance.yahoo.comCheap UK shares: 1 I am considering right nowSeptember 11, 2021 | fool.co.ukAmryt Pharma PLC ADRAugust 13, 2021 | barrons.comAmryt Pharma PLC - Holding(s) in CompanyAugust 11, 2021 | proactiveinvestors.comAmryt Reports Record Q2 2021 Results and Raises FY 2021 GuidanceAugust 6, 2021 | finance.yahoo.com Get Amryt Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Uncover the Top Gold Stock of the Bull Market (Ad)Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play? Click here to see how this opportunity could transform your portfolio. AMYT Media Mentions By Week AMYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMYT News Sentiment▼0.000.54▲Average Medical News Sentiment AMYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMYT Articles This Week▼00▲AMYT Articles Average Week Get Amryt Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ithaca Energy News Today Grainger News Today Indivior News Today Bloomsbury Publishing News Today Global Ports News Today India Capital Growth News Today Alpha Real Trust News Today Pharos Energy News Today Kodal Minerals News Today Aura Energy News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AMYT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amryt Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Amryt Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
